Results 171 to 180 of about 10,436 (217)

A peptide display system identifies a potent mutant β-melanocyte-stimulating hormone agonist of melanocortin-4 receptor. [PDF]

Cell Genom
Lin A, Spees K, Valbuena R, Wirbel J, Natarajan A, Enright N, Bhatt AS, Bassik MC.   +7 more
europepmc   +1 more source

Physical exercise increases binding of POMC to blood extracellular vesicles. [PDF]

Proc Natl Acad Sci U S A
Santos MF, Randa J, Tai D, Vistoli G, Schahaf NA, Vittorio S, Fuentes G, Lauro R, Mosallaei S, Karbanová J, Yokomizo AMK, Corbeil D, Hightower CE, Lorico A.   +13 more
europepmc   +1 more source

Biological Roles of Melanin and Natural Product-Derived Approaches for Its Modulation. [PDF]

Int J Mol Sci
Hong S, Lim H, Kim DH.
europepmc   +1 more source

Breed difference in the regulation of feather coloration in chickens [PDF]

, 2014
Nishio, Kaori, Ogoshi, Maho, Takahashi, Sumio, Takahashi, Toru, Takeuchi, Sakae   +4 more
core  

Comparative Efficacy of Skin-Lightening Formulations in Suppressing Ultraviolet B (UVB)-Induced Arachidonic Acid, Alpha-Melanocyte-Stimulating Hormone (α-MSH), and Melanin Expression: An In Vitro Keratinocyte-Melanocyte Co-culture Study. [PDF]

Cureus
Ribero S, Romani A, Mattozzi C, Minoretti P.   +3 more
europepmc   +1 more source

Natural dual inhibitor isorhamnetin-3-O-neohespeidoside targets tyrosinase and MC1R for skin pigmentation management. [PDF]

Sci Rep
Deng R, Zheng S, Xie S, Huang G, Ou Z, Shen Z.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Age-dependence of alpha-MSH-induced anorexia

Neuropeptides, 2010
Long-term regulation of energy balance involves two major trends: first age-related obesity develops in the middle-aged, later it is followed by anorexia of aging (sarcopenia and/or cachexia). A dynamic balance between orexigenic and anorexigenic neuropeptides is essential for the regulation of energy homeostasis.
E, Pétervári, A, Garami, S, Soós, M, Székely, M, Balaskó   +4 more
openaire   +2 more sources

Ingested (oral) alpha-MSH inhibits acute EAE

Journal of Neuroimmunology, 2008
Ingested type I IFN and SIRS peptide administered orally inhibit EAE. We examined whether another immunoactive protein, tridecapeptide alpha-MSH, would have similar anti-inflammatory effects in EAE after oral administration. B6 mice were immunized with MOG peptide 35-55 and gavaged with 0.1 ml of control saline or alpha-MSH peptide starting on day -7 ...
Staley A, Brod, Zachary M, Hood
openaire   +2 more sources

ALPHA-MSH STIMULATION OF GROWTH HORMONE RELEASE

The Journal of Clinical Endocrinology & Metabolism, 1973
The tridecapeptide 1–13 of human ACTH (∞-MSH) was found to induce GH release in 18 among 23 normal males ; peak values occurred at 30 or 45 min. ∞-MSH was given IV over 1 min at a dose of 0.5 mg. No change in blood cortisol or glucose were found while minimal side effects occurred in only 4 subjects. GH did not rise after placebo injection.
G, Strauch, D, Girault, M, Rifaĭ, H, Bricaire   +3 more
openaire   +2 more sources

Acute phase response to endotoxin: rise in plasma alpha-MSH and effects of alpha-MSH injection

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1990
Endotoxins, cell wall components of bacteria, cause a number of biological effects, presumably via induction of potent cytokines. Previous research suggests that the neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) and its COOH-terminal tripeptide reduce the effects of cytokines.
L W, Martin, J M, Lipton
openaire   +2 more sources